Rapid Waning and Short-Lived Immunity: It’s Time to Rethink COVID Booster Shots, Israeli Researchers Say

By Lia Onely

An Israeli study has concluded that the short-lived immunity and rapid waning of the Pfizer BioNTech COVID-19 vaccine necessitates the reevaluation of future COVID-19 vaccination campaigns.

The authors said that while the vaccine was effective in decreasing morbidity and mortality, “its relatively small effect on transmissibility of Omicron … and its rapid waning call for reassessment of future booster campaigns.”

The peer-reviewed paper was published on Nov. 7 in Nature Communications…